Comparing Capecitabine vs Enhertu
| Capecitabine | Enhertu (fam-trastuzumab deruxtecan) |
|
|---|
| Capecitabine | Enhertu (fam-trastuzumab deruxtecan) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Colorectal Cancer, Breast Cancer - Metastatic, Pancreatic Cancer, Breast Cancer, Stomach Cancer, Esophageal Carcinoma, Anal Cancer, Non Small Cell Lung Cancer, Prostate Cancer, Renal... View more |
Prescription only
Prescribed for Breast Cancer - Metastatic, Breast Cancer, Non Small Cell Lung Cancer, Solid Tumors, Gastric Cancer. Enhertu may also be used for purposes not listed in this medication guide. |
Related suggestions Breast Cancer
Popular comparisons
|
|||||||||||||||
| More about Capecitabine | More about Enhertu (fam-trastuzumab deruxtecan) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Capecitabine has an average rating of 6.7 out of 10 from a total of 61 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 26% reported a negative effect. |
Enhertu has an average rating of 8.0 out of 10 from a total of 30 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 3% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Capecitabine side effects |
View all Enhertu side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Capecitabine prices |
View all Enhertu prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Xeloda |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
0.75 hours |
136.8 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 289 drugs are known to interact with Capecitabine:
|
A total of 175 drugs are known to interact with Enhertu:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
April 30, 1998 |
N/A |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.